Cover Image
市場調查報告書

全球藥價、給付制度旅遊指南

The Worldwide Guide to Pharmaceutical Pricing and Reimbursement

出版商 Espicom Business Intelligence 商品編碼 316057
出版日期 內容資訊 英文 199 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球藥價、給付制度旅遊指南 The Worldwide Guide to Pharmaceutical Pricing and Reimbursement
出版日期: 2014年07月01日 內容資訊: 英文 199 Pages
簡介

本報告提供全球醫藥品價格及給付制度的各國分析。

序文

摘要整理

藥價&給付制度

  • 自由價格制與間接制
  • 以價值為基準的價格
  • 標準價格
    • 外部標準價格
    • 內部標準價格
  • 批發、藥局的賣價
  • 給付清單
    • 陽性陰性列表
    • 必需醫藥品

南北美洲

  • 阿根廷
  • 巴西
  • 加拿大
  • 智利
  • 哥倫比亞
  • 墨西哥
  • 秘魯
  • 美國
  • 委內瑞拉

亞太地區

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 紐西蘭
  • 巴基斯坦
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

中東歐

  • 白俄羅斯
  • 保加利亞
  • 克羅埃西亞
  • 捷克
  • 愛沙尼亞
  • 匈牙利
  • 拉脫維亞
  • 立陶宛
  • 波蘭
  • 羅馬尼亞
  • 俄羅斯
  • 塞爾維亞
  • 斯洛伐克
  • 斯洛維尼亞
  • 烏克蘭

中東/非洲

  • 埃及
  • 以色列
  • 科威特
  • 摩洛哥
  • 沙烏地阿拉伯
  • 南非
  • 土耳其
  • 阿拉伯聯合大公國(UAE)

西歐

  • 奧地利
  • 比利時
  • 丹麥
  • 芬蘭
  • 法國
  • 德國
  • 希臘
  • 愛爾蘭
  • 義大利
  • 荷蘭
  • 挪威
  • 葡萄牙
  • 西班牙
  • 瑞典
  • 瑞士
  • 英國

資訊來源

目錄

For budget conscious healthcare providers, "value" has become a widely used term that plays a central role in the decision-making process alongside quality of care, particularly for pharmaceuticals.

Increasingly, value is expressed in economic as well as medical terms and companies are expected to provide evidence of both. In some markets, economic assessment has been formalised and takes place alongside an assessment of medical benefit. The broader concept of value is, therefore, open to varying interpretations around the world, depending on the local needs of national and regional healthcare providers and has become central to pricing and reimbursement decision-making processes.

Table of Contents

FOREWORD

EXECUTIVE SUMMARY

PRICING & REIMBURSEMENT SYSTEMS

  • Free Pricing and Indirect Control
  • Value-Based Pricing
  • Reference Pricing
    • External Reference Pricing
      • Concerns and Limitations of External Reference Pricing
    • Internal Reference Pricing
      • Fixed Generic Price Reductions
  • Wholesale and Pharmacy Mark-ups
  • Reimbursement Lists
    • Positive and Negative Lists
    • Essential Medicines

AMERICAS

ARGENTINA

  • Pricing
    • Price Controls in the National Medicines Policy
  • Reimbursement

BRAZIL

  • Pricing
    • Drug Price Set-up
    • Drug Price Control
  • Reimbursement
    • Popular Pharmacy Programme

CANADA

  • Pricing
  • Reimbursement
    • Provincial Formularies
      • Recent Developments
    • Drug Insurance Programmes
    • National Pharmaceuticals Strategy
    • Orphan Drugs

CHILE

  • Pricing
    • Public Procurement
    • Reimbursement

COLOMBIA

  • Pricing
    • Price Regulation
      • Resolutions/Decrees Issued in 2010
      • Resolution No. 04/2006
    • Reference Pricing
    • SISMED
  • Reimbursement

MEXICO

  • Pricing
    • Private Sector
    • Public Procurement
      • Seguro Popular
    • Recent Developments
  • Reimbursement

PERU

  • Pricing
    • Public Procurement
      • Reverse Auctions
      • Public Monitoring
      • OPPF
  • Reimbursement
    • PNUM

USA

  • Pricing
    • Public Drug Procurement
    • Average Wholesale Price (AWP)
    • Biologics Price Competition and Innovation Act
  • Reimbursement
    • Medicaid
    • Medicare
      • Legislative Background
      • Bill H.R.1
  • State Pricing/Reimbursement Moves

VENEZUELA

  • Pricing
    • Regulation
      • Background to Price Control
    • Foreign Exchange Controls
  • Reimbursement

ASIA/PACIFIC

AUSTRALIA

  • Pricing
    • Drug Pricing Developments
      • PBS Drug Price Cuts
      • PBS Medicine Bill Reforms
    • Reference Pricing System
      • 12.5% Price Reductions for New Market Entrants
    • US Free Trade Agreement
  • Reimbursement
    • PBS Formularies
    • Patient Co-Payments
  • Health Technology Assessment

CHINA

  • Pricing
    • Essential Drugs List
    • Price Reductions
    • Retail Price Limits Eased
    • Mandatory Licensing
  • Reimbursement
    • Patient Contributions

INDIA

  • Pricing
    • Drugs (Prices Control) Order, 2013
    • National Pharmaceuticals Pricing Policy, 2012
      • Background
      • NPPP-2012 and NLEM-2011
    • Reimbursement

INDONESIA

  • Pricing
    • Price Changes
  • Essential Drugs List
  • Reimbursement

JAPAN

  • Pricing
    • Price Reductions
  • Reimbursement
  • National Health Insurance Drug Price List

MALAYSIA

  • Pricing

NEW ZEALAND

  • Pricing
    • Drug Tender Scheme
  • Reimbursement
    • Prescription Charges

PAKISTAN

  • Pricing
    • Drug Pricing Policy
    • Medicine Tariffs Abolished
    • Illegal Price Increases
  • Reimbursement

PHILIPPINES

  • Pricing
    • Government Mediated Access Price
      • Further Price Reductions, 2010
      • DoH issues Cease and Desist Orders on retailers that violate the GMAP and MRP
    • Essential Medicines Price Freeze
  • Reimbursement

SINGAPORE

  • Pricing
  • Reimbursement

SOUTH KOREA

  • Pricing
    • Key Developments
      • Drug Price Cuts to Encourage Generic Competition
      • Preferential Drug Price-Cut Exemption Policy
      • Transacted Drug Price Control System
      • Separation of Prescribing and Dispensing
  • Reimbursement
    • Actual Transaction Price Schemes

TAIWAN

  • Pricing
    • NHIA Price Cuts
  • Reimbursement
    • Co-payment system

THAILAND

  • Pricing
  • Reimbursement

VIETNAM

  • Pricing
    • Drug Price Regulation
    • Cuts in Tax & Import Duties
    • Price Adjustments
      • Regional Price Comparison
    • Recent Developments
  • Reimbursement
    • Health Insurance Fund Deficits
    • Increase in Hospital Fees

CENTRAL AND EASTERN EUROPE

BELARUS

  • Pricing
    • Wholesale and Retail Mark-ups
  • Reimbursement
    • Tendering Procedures

BULGARIA

  • Pricing
    • Reference Pricing
  • Reimbursement

CROATIA

  • Pricing
    • Reference Pricing
    • VAT
    • Price Cuts
    • Wholesale Margins
  • Reimbursement

CZECH REPUBLIC

  • Pricing
    • Reference Pricing
      • Price Application Procedure
    • Reimbursement

ESTONIA

  • Pricing
    • Reference Pricing
    • VAT
  • Reimbursement
  • Supplementary Benefit for Pharmaceuticals
  • Reimbursement Application Process

HUNGARY

  • Pricing
    • Reference Pricing
    • Pricing Developments
    • Wholesale and Pharmacy Mark-ups
    • VAT
  • Reimbursement

LATVIA

  • Pricing
    • Reference Pricing
    • Pricing Developments
    • VAT
  • Reimbursement

LITHUANIA

  • Pricing
    • Reference Pricing
    • VAT
  • Reimbursement

POLAND

  • Pricing
    • Reference Pricing
    • Wholesale and Pharmacy Mark-ups
    • VAT
  • Reimbursement
    • Recent Developments

ROMANIA

  • Pricing
    • Reference Pricing
    • Wholesale and Pharmacy Mark-ups
    • VAT
  • Reimbursement

RUSSIA

  • Pricing
    • Vital & Essential Medicines List
    • Reference Pricing
    • Wholesale and Retail Mark-ups
    • Maximum Prices
    • Changes to State Tenders
    • Medicines Financing
  • Reimbursement
    • DLO Programme
      • DLO Budget
      • DLO Procurement
      • Cancer Treatments
      • Proposed Orphan Drugs Programme

SERBIA

  • Pricing
    • Reference Pricing
    • VAT
    • Medicines Shortages
  • Reimbursement

SLOVAKIA

  • Pricing
    • Reference Pricing
    • Wholesale and Pharmacy Mark-ups
    • VAT
  • Reimbursement

SLOVENIA

  • Pricing
    • Reference Pricing
    • Wholesale Mark-ups
    • VAT
  • Reimbursement

UKRAINE

  • Pricing
    • VAT Exemption
    • Price Ceilings and Mandatory Price Change Notification
    • Reference Pricing Proposal
  • Reimbursement
    • Pilot Project for Hypertension Patients

MIDDLE EAST/AFRICA

EGYPT

  • Pricing
    • Reference Pricing
    • Recent Pricing Issues
  • Reimbursement

ISRAEL

  • Pricing
    • Reference Pricing
  • Reimbursement

KUWAIT

  • Pricing
    • Regional Harmonisation
  • Reimbursement
    • Public Procurement of Medicines

MOROCCO

  • Pricing
    • Reference Pricing
    • Parliamentary Drug Pricing Report
    • Price Reductions
  • Reimbursement

SAUDI ARABIA

  • Pricing
    • Reference Pricing
      • Pricing System Reform
    • Tendering Procedures
      • National Unified Procurement Company for Medical Supplies
  • Reimbursement

SOUTH AFRICA

  • Pricing
    • Reference Pricing
    • Dispensing Fees Charged by Pharmacists
  • Reimbursement
    • Essential Medicines List

TURKEY

  • Pricing
    • Reference Pricing
    • Wholesale and Pharmacy Mark-ups
    • Price Cuts
  • Reimbursement

UNITED ARAB EMIRATES

  • Pricing
    • Importer and Pharmacy Mark-ups
    • Price Reductions
    • Regional Harmonisation
    • Pharmaceutical Tenders
  • Reimbursement
    • Pharmacy Benefit Management
    • Health Card for Expats

WESTERN EUROPE

AUSTRIA

  • Pricing
    • Reference Pricing
    • Price Notification System
    • Hospital Medicines
    • Wholesaler and Pharmacy Mark-ups
    • VAT
  • Reimbursement
    • Erstattungskodex (EKO)
    • Rational Use of Pharmaceuticals
    • Patient Co-payments

BELGIUM

  • Pricing
    • Reference Pricing
    • Cost Control Policies
  • Reimbursement
    • Patient Co-payments

DENMARK

  • Pricing
    • Reference Pricing
    • Medicine Prices
    • Price Index
    • VAT
    • Pharmacy Prices Decline
  • Reimbursement
    • Executive Order
    • Reimbursement Thresholds

FINLAND

  • Pricing
    • Reference Pricing and Generic Substitution
    • Price Cuts and Trends
  • Reimbursement
    • Reimbursement Categories
      • Basic Reimbursement
      • Special Reimbursement
    • Patient Co-payments

FRANCE

  • Pricing
    • Internal Reference Pricing
    • Formal Medico-Economic Assessment
    • VAT
    • Government Cost Saving Measures
  • Reimbursement
    • Patient co-payments
    • Index Therapeutique Relatif

GERMANY

  • Pricing
    • Evidential Requirements Under AMNOG
      • Amendment to the Law on Medicines Regarding Comparator Therapies
      • IQWiG
      • Industry Concerns
    • Reference Pricing
    • Generic Substitution Policies
    • Pharmaceutical Discount Contracts
    • VAT
  • Reimbursement
    • Patient co-payments

GREECE

  • Pricing
    • Pricing Regime Developments
    • Reference Price System
    • Wholesale and Retail Margins
    • VAT
  • Reimbursement
    • Social Insurance and Reimbursement Categories
    • Patient Co-payments

IRELAND

  • Pricing
    • Reference Pricing and Generic Substitution
    • Wholesale Margins
  • Reimbursement
    • HSE Primary Care Reimbursement Service (PCRS)
    • Reimbursement Policies Create Drug Shortages
    • Prescription Charges

ITALY

  • Pricing
  • Reimbursement
    • Expenditure Capping and Payback
    • Tendering System
    • Risk Sharing

NETHERLANDS

  • Pricing
    • Reference Pricing
    • Pricing Developments
    • VAT
    • Pharmacy Fees
  • Reimbursement
    • Generic Substitution

NORWAY

  • Pricing
    • Reference Pricing System
    • Generic Pricing System
    • Wholesale and Pharmacy Mark-ups
    • Sales Tax and VAT
  • Reimbursement
    • First-Choice Scheme
    • Patient Co-payments

PORTUGAL

  • Pricing
    • Reference Pricing System
    • Generics
    • VAT
  • Reimbursement

SPAIN

  • Pricing
    • Reference pricing
    • Regional Variations
    • Drug Price Discounts
    • Pharmacy Margins
  • Reimbursement
    • Generic prescribing
    • Tendering System
      • Regional Tenders
    • Patient Co-payments

SWEDEN

  • Pricing
    • VAT
  • Reimbursement
    • Reimbursement Rates

SWITZERLAND

  • Pricing
    • Reference Pricing
    • Wholesale Mark-ups
    • Pricing Agreement
  • Reimbursement
    • Patient Co-payments

UNITED KINGDOM

  • Pricing
    • PPRS 2014
    • Generics
  • Reimbursement
    • Patient Access Schemes
    • Prescription Charges

SOURCES

Back to Top